• Explore /
  • Poster
  • / Neutrophil/lymphocyte ratio (NLR) may predict prognostic factor with gemcitabine, cisplatin (GC) for patients with advanced biliary tract cancer.

Neutrophil/lymphocyte ratio (NLR) may predict prognostic factor with gemcitabine, cisplatin (GC) for patients with advanced biliary tract cancer.

Abstract Poster

Authors

null

Toru Otsuru

Department of Frontier Science for Cancer and Chemotherapy Osaka University Graduate School of Medicine, Osaka, Japan

Toru Otsuru , Daisuke Sakai , Akie Kimura , Chiaki Inagaki , Naohiro Nishida , Yoshifumi Iwagami , Takehiro Noda , Tadafumi Asaoka , Kunihito Gotoh , Shogo Kobayashi , Hidetoshi Eguchi , Taroh Satoh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 410)

DOI

10.1200/JCO.2019.37.4_suppl.410

Abstract #

410

Poster Bd #

M10

Abstract Disclosures

Similar Posters

First Author: Richard D. Kim

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Prognostic effects of co-occurring <i>TP53</i> and <i>KRAS</i> aberrations in patients with advanced biliary tract cancer.

Prognostic effects of co-occurring TP53 and KRAS aberrations in patients with advanced biliary tract cancer.

First Author: Taro Shibuki

First Author: Mohamed Bouattour

First Author: John Ebben